Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd Share Price(AARTIPHARM)

Check the latest share price of Aarti Pharmalabs Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹880.55

0.18%

as on 04:01PM, 27 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Aarti Pharmalabs Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹872.1
    Day's Price Range
    ₹884.9
  • 52 Week's Low

    52 Week's High

    ₹497.05
    52-Week Price Range
    ₹884.9
1 Month Return+ 20.58 %
3 Month Return+ 18.74 %
1 Year Return+ 51.02 %
3 Year Return+ 204.93 %
5 Year Return+ 204.93 %
Previous Close₹878.95
Open₹878.95
Volume3.28L
Upper Circuit₹1,054.70
Lower Circuit₹703.20

Aarti Pharmalabs Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹7,966.33 Cr

Return on Equity (ROE)

13.11

PE Ratio (TTM)

29.24

Return on capital employed (ROCE)

16.4

Industry PE ratio

55.37

Beta (LTM)

1.02

P/B Ratio

2.43

Dividend Yield

0.69

PEG Ratio

4.78

Quarterly Earnings Growth YOY

35.39

EPS (TTM)

23.93

Sector

Pharmaceuticals

Book Value

193.88

Technical Analysis

How to invest in Aarti Pharmalabs Ltd?

Investing in Aarti Pharmalabs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Aarti Pharmalabs Ltd or AARTIPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Aarti Pharmalabs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Aarti Pharmalabs Ltd with just a few clicks!

Aarti Pharmalabs Ltd Stock's Interest Amongst Investors

-18%

Period May 27, 2025 to Apr 27, 2025. Change in 30 Days vs previous period

Search interest for Aarti Pharmalabs Ltd Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Aarti Pharmalabs Ltd Valuation

Track how the P/E of Aarti Pharmalabs Ltd has moved over time to understand valuation trends.

Aarti Pharmalabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (29.24x)

May 26, 2025

Industry (55.37x)

May 26, 2025

Highest (29.40x)

February 18, 2025

LowHigh

Today’s Price to Earnings Ratio: 29.24x

Aarti Pharmalabs Ltd Financials

Get the annual and quarterly financial summary of Aarti Pharmalabs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue

(in ₹ Cr)

506 (0%)555 (10%)458 (18%)538 (17%)564 (5%)
Net Income

(in ₹ Cr)

65 (0%)55 (15%)55 (2%)74 (35%)88 (19%)
Net Profit Margin12.90% (0%)9.98% (23%)11.92% (19%)13.76% (15%)15.67% (14%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

0 (0%)1827 (730632%)1978 (8%)2299 (16%)
Total Liabilities

(in ₹ Cr)

0 (0%)543 (2712700%)540 (1%)678 (26%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

-0 (0%)0 (100%)-65 (0%)216 (433%)184 (15%)

Aarti Pharmalabs Ltd Index Inclusions

BSE Healthcare

₹42,666.15

0.01 (3.46%)

BSE Small-Cap

₹51,865.29

0.19 (98.57%)

Aarti Pharmalabs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Aarti Pharmalabs Ltd.

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit jumped 35.39% since last year same period to ₹88.34Cr in the Q4 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 19.39% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Pharmalabs Ltd Dividends February,2025

    In the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.62%.

    Read More about Dividends

Aarti Pharmalabs Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Pharmalabs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.29%
0.00
Foreign Institutions
7.36%
0.00
Mutual Funds
0.78%
0.00
Retail Investors
40.81%
0.00
Others
6.76%
0.00

Aarti Pharmalabs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA7,966.3340.99%0.572161,852
NA34.3113.57%0.54NANA
NA1,903.8413.22%0.79-84473
NA882.935.26%0.68-25335
NA4,292.6476.82%0.52-711,704

Aarti Pharmalabs Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Aarti Pharmalabs Ltd.

  • Aarti Pharmalabs Reports Strong Q4 Results - 15 May, 2025

    Aarti Pharmalabs reported standalone net sales of Rs 529.62 crore for March 2025, a 27.68% increase year-on-year. Net profit rose 40.98% to Rs 88.85 crore, with EBITDA up 24.42%. EPS increased to Rs 9.80 from Rs 6.95.
  • Aarti Pharmalabs Q4 Profit Up 35.38% - 12 May, 2025

    Aarti Pharmalabs reported a 35.38% increase in consolidated net profit to Rs 88.34 crore for Q4 FY25, with revenue rising 11.46% YoY. The company also announced a dividend of Rs 2.5 per share, pending shareholder approval.
  • Aarti Pharmalabs Reports Strong Q3 Growth - 03 May, 2025

    Aarti Pharmalabs Limited, a leading manufacturer of APIs and xanthine derivatives, reported a 20% revenue increase to Rs. 542.81 crore and a net profit rise to Rs. 73.99 crore in Q3FY24-25.
  • Aarti Pharmalabs Reports Strong Q3 Growth - 18 Apr, 2025

    Aarti Pharmalabs' stock increased by 2.3% to Rs. 733.9, supported by a 20% YoY revenue growth to Rs. 538 crores and a 40% rise in net profit.
  • Aarti Pharmalabs Achieves SBTi Emission Targets Approval - 16 Apr, 2025

    Aarti Pharmalabs has received official approval from the Science Based Targets initiative for its emission reduction goals across all scopes, marking a significant commitment to sustainability. This achievement aligns with the Paris Agreement and enhances the company's appeal to environmentally focused partners.

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 54.62 Cr → 88.34 Cr (in ₹), with an average increase of 21.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AARTIPHARM stock has moved up by 20.6%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 36.33% to 40.81% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 462.51 Cr → 562.17 Cr (in ₹), with an average increase of 9.1% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 44.66% to 44.29% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 3.93% to 0.78% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.64% to 7.36% in Mar 2025 quarter

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients API Pharmaceutical Intermediates New Chemical Entities NCE and Xanthine Derivatives situated in India.In 2001 the Company commissioned first API manufacturing Unit in Dombivali Unit 1 and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes MT per month in 2016. It expanded block for CSD Vapi and API Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17 2022 and operational from July 1 2021. Pursuant to the said Demerger Scheme Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter the Company in 2023 commercialised Block V at Tarapur Unit 4. Again it enhanced Xanthine capacity to 5000 TPA in 2023.90626008 Equity Shares of Rs 5/ each got listed effective January 30 2023..

Revenue: ₹563.78Cr as on March 2025 (Q1 25)
Net Profit: ₹88.34Cr as on March 2025 (Q1 25)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEORashesh C Gogri
E-voting on sharesClick here to vote

Indian Mutual Funds that own Aarti Pharmalabs Ltd

Check out the Mutual Funds with significant holdings in Aarti Pharmalabs Ltd.

FAQs

What is Aarti Pharmalabs Ltd price today?

Aarti Pharmalabs Ltd share price today stands at ₹880.55, Open: ₹878.95, Previous Close: ₹878.95, High: ₹884.9, Low: ₹872.1, 52 Week High: ₹884.9, 52 Week Low: ₹497.05.

How to Buy Aarti Pharmalabs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Aarti Pharmalabs Ltd shares

What are today's traded volumes of Aarti Pharmalabs Ltd?

Today's traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 3.28L.

What is today's market capitalisation of Aarti Pharmalabs Ltd?

Today's market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹7,966.33 Cr.

What is the 52 Week High and Low Range of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd (AARTIPHARM)
Price
52 Week High
₹884.9
52 Week Low
₹497.05

How much percentage Aarti Pharmalabs Ltd is down from its 52 Week High?

Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹880.55. It is down -0.49% from its 52 Week High price of ₹884.9

How much percentage Aarti Pharmalabs Ltd is up from its 52 Week low?

Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹880.55. It is up 77.16% from its 52 Week Low price of ₹497.05